Venous thromboembolism (VTE) is the third most common cause of vascular mortality
worldwide and comprises deep-vein thrombosis (DVT) and pulmonary embolism (PE). In …

Background Combined oral contraceptives (COC s) containing various progestogens could
be associated with differential risks for venous thromboembolism (VTE). Objective To …

Summary The 2016 US Medical Eligibility Criteria for Contraceptive Use (US MEC)
comprises recommendations for the use of specific contraceptive methods by women and …

Importance It is uncertain to what extent established cardiovascular risk factors are
associated with venous thromboembolism (VTE). Objective To estimate the associations of …

Background Combined oral contraceptive (COC) use has been associated with venous
thrombosis (VT)(ie, deep venous thrombosis and pulmonary embolism). The VT risk has …

Medical Eligibility Criteria for Contraceptive Use reviews the medical eligibility criteria for
use of contraception, offering guidance on the safety and use of different methods for women …

Objective To provide a comprehensive overview of the risk of venous thrombosis in women
using different combined oral contraceptives. Design Systematic review and network meta …

Objective To assess the risk of venous thromboembolism from use of combined oral
contraceptives according to progestogen type and oestrogen dose. Design National …

Until the 1990s, venous thromboembolism (VTE) was viewed primarily as a complication of
hospitalization for major surgery (or associated with the late stage of terminal illness) …

Background Polycystic ovary syndrome (PCOS) is associated with obesity and low grade
inflammation and the risk for cardiovascular disease (CVD) could be increased in PCOS …